Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cue Biopharma, Inc.

0.6952
+0.00320.46%
Post-market: 0.6703-0.0249-3.58%15:58 EDT
Volume:66.63K
Turnover:46.44K
Market Cap:52.38M
PE:-1.07
High:0.7098
Open:0.6920
Low:0.6700
Close:0.6920
Loading ...

Cue Biopharma announces presentation of new CUE-101 data

TIPRANKS
·
02 Jul

BRIEF-Cue Biopharma Updates on CUE-101 at DAVA 4th Hawaii Summit

Reuters
·
02 Jul

Cue Biopharma Inc - Orr of 50% in Hpv+ R/M Hnscc Patients

THOMSON REUTERS
·
02 Jul

Cue Biopharma Provides Update on Most Advanced Clinical Stage Asset, Cue-101, Presented by DR. Dimitrios Colevas at the Dava 4TH Hawaii Global Summit on Thoracic Malignancies

THOMSON REUTERS
·
02 Jul

Cue Biopharma Inc - 12-Month Survival of 88% and Mos of 32 Months

THOMSON REUTERS
·
02 Jul

Cue Biopharma Receives FDA Feedback for Trial Design of Drug Candidate to Treat Autoimmune Diseases

MT Newswires Live
·
25 Jun

Cue Biopharma Receives FDA Feedback on Pre-Ind Briefing Document Reinforcing Company’s Intention to Advance Ind Submission for Cue-401 to Address Unmet Need in the Treatment of Autoimmune Disease

THOMSON REUTERS
·
25 Jun

Cue Biopharma CFO Kerri-Ann Millar to Depart

MT Newswires Live
·
11 Jun

BRIEF-Cue Biopharma CEO Daniel Passeri To Serve As Interim CFO

Reuters
·
11 Jun

Cue Biopharma Inc - Kerri-Ann Millar Resigns as CFO - SEC Filing

THOMSON REUTERS
·
11 Jun

Cue Biopharma Inc. Files Initial Beneficial Ownership Statement for Director Jill Marie Broadfoot

Reuters
·
07 Jun

Cue Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
13 May

Cue Biopharma Q1 EPS $(0.17) Misses $(0.15) Estimate, Sales $421.00K Miss $1.27M Estimate

Benzinga
·
13 May

Cue Biopharma Inc. Reports Q1 2025 Results: Revenue Falls to $0.4M, Net Loss at $12.3M, EPS at $(0.17)

Reuters
·
13 May

Cue Biopharma Inc expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
09 May

Cue Biopharma to Participate in Fireside Chat at the Citizens Life Sciences Conference

GlobeNewswire
·
05 May

Cue Biopharma Inc expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
05 May

Will Cue Biopharma, Inc. (CUE) Report Negative Q1 Earnings? What You Should Know

Zacks
·
01 May

BRIEF-Cue Biopharma Prices Common Stock And Warrants At $0.79 Per Share; Pre-Funded Warrants At $0.789

Reuters
·
15 Apr